Allan E. Rettie

16.9k total citations · 3 hit papers
214 papers, 12.9k citations indexed

About

Allan E. Rettie is a scholar working on Pharmacology, Oncology and Biochemistry. According to data from OpenAlex, Allan E. Rettie has authored 214 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pharmacology, 66 papers in Oncology and 42 papers in Biochemistry. Recurrent topics in Allan E. Rettie's work include Pharmacogenetics and Drug Metabolism (157 papers), Drug Transport and Resistance Mechanisms (61 papers) and Eicosanoids and Hypertension Pharmacology (35 papers). Allan E. Rettie is often cited by papers focused on Pharmacogenetics and Drug Metabolism (157 papers), Drug Transport and Resistance Mechanisms (61 papers) and Eicosanoids and Hypertension Pharmacology (35 papers). Allan E. Rettie collaborates with scholars based in United States, Germany and United Kingdom. Allan E. Rettie's co-authors include William Trager, Robert L. Haining, Mark J. Rieder, Frank J. Gonzalez, Jeffrey P. Jones, Kenneth R. Korzekwa, Kenneth E. Thummel, David L. Veenstra, Matthew G. McDonald and Thomas A. Baillie and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of the American Chemical Society.

In The Last Decade

Allan E. Rettie

209 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose

2005 988 citations Mark J. Rieder, Deborah A. Nickerson et al. profile →
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”

2006 639 citations Mary F. Paine, Allan E. Rettie et al. Drug Metabolism and Disposition profile →
Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1992 494 citations Allan E. Rettie, Kenneth R. Korzekwa et al. Chemical Research in Toxicology profile →

Peers

Countries citing papers authored by Allan E. Rettie

Since Specialization

Citations

This map shows the geographic impact of Allan E. Rettie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan E. Rettie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan E. Rettie more than expected).

Fields of papers citing papers by Allan E. Rettie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan E. Rettie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan E. Rettie. The network helps show where Allan E. Rettie may publish in the future.

Co-authorship network of co-authors of Allan E. Rettie

This figure shows the co-authorship network connecting the top 25 collaborators of Allan E. Rettie. A scholar is included among the top collaborators of Allan E. Rettie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan E. Rettie. Allan E. Rettie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytochrome P450 Family 4F2 and 4F11 Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity 2024 ·ACS Pharmacology & Translational Science ·(unknown), Katrina G. Claw, Matthew G. McDonald, Bhagwat Prasad, Allan E. Rettie, Kenneth E. Thummel	1
2	Spotlight on CYP4B1 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Michael C. Hutter, Allan E. Rettie, Helmut Hanenberg, Constanze Wiek, Marco Girhard	11
3	Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems 2023 ·Journal of Chromatography B ·(unknown), Allan E. Rettie, (unknown)	2
4	Experimental pharmacology in precision medicine 2023 ·Pharmacology Research & Perspectives ·Alicja Urbaniak, Kenneth E. Thummel, (unknown), Allan E. Rettie, Bhagwat Prasad, Amedeo De Nicolò, Jennifer Martin, David N. Sheppard, Michael F. Jarvis	4
5	A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects with Various CYP2C9 Genotypes under Different Cotreatments 2022 ·Drug Metabolism and Disposition ·Cheng Shen, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage, Timothy S. Tracy	5
6	Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach 2021 ·Pharmacological Reviews ·Emily J. Cox, Dandan Tian, John Clarke, Allan E. Rettie, Jashvant D. Unadkat, Kenneth E. Thummel, Jeannine S. McCune, Mary F. Paine	15
7	Massively parallel characterization of CYP2C9 variant enzyme activity and abundance 2021 ·The American Journal of Human Genetics ·(unknown), Melissa A. Chiasson, Matthew G. McDonald, Lai Hong Wong, Katherine A. Sitko, Gabriel Boyle, (unknown), Allan E. Rettie, Douglas M. Fowler, Maitreya J. Dunham	61
8	Dietary and genetic influences on hemostasis in a Yup’ik Alaska Native population 2017 ·PLoS ONE ·(unknown), Morayma Reyes, Bert B. Boyer, Scarlett E. Hopkins, (unknown), Diane M. O’Brien, Alison E. Fohner, (unknown), Timothy A. Thornton, Melissa A. Austin, Wylie Burke, Kenneth E. Thummel, Allan E. Rettie	7
9	Efficient Syntheses of Vitamin K Chain-Shortened Acid Metabolites 2015 ·Synthesis ·Aaron M. Teitelbaum, Michele Scian, Wendel L. Nelson, Allan E. Rettie	7
10	Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. 2014 ·The Medicine Forum ·Kelly E. Caudle, Allan E. Rettie, Michelle Whirl‐Carrillo, (unknown), Scott Mintzer, M T M Lee, Teri E. Klein, J. Callaghan	6
11	Human Valacyclovir Hydrolase/Biphenyl Hydrolase-Like Protein Is a Highly Efficient Homocysteine Thiolactonase 2014 ·PLoS ONE ·Judit Marsillach, Stephanie M. Suzuki, Rebecca J. Richter, Matthew G. McDonald, (unknown), Michael J. MacCoss, Edward J. Hsieh, Allan E. Rettie, Clement E. Furlong	31
12	Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue 2011 ·PLoS Genetics ·Federico Innocenti, Gregory M. Cooper, Ian B. Stanaway, Eric R. Gamazon, Joshua D. Smith, Snezana Mirkov, Jacqueline Ramı́rez, Wanqing Liu, Yvonne S. Lin, (unknown), (unknown), Nathan D. Trinklein, Erin G. Schuetz, Deborah A. Nickerson, Ken Thummel, Mark J. Rieder, Allan E. Rettie, Mark J. Ratain, Nancy J. Cox, Christopher D. Brown	134
13	A case study of acenocoumarol sensitivity and genotype‐phenotype discordancy explained by combinations of polymorphisms in VKORC1 and CYP2C9 2006 ·British Journal of Clinical Pharmacology ·Allan E. Rettie, Frederico M. Farin, (unknown), (unknown), Mark J. Rieder, H.H.W. Thijssen	20
14	Developmental Expression of Human Hepatic CYP2C9 and CYP2C19 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Sevasti B. Koukouritaki, Jason R. Manro, (unknown), Jeffrey Stevens, Allan E. Rettie, D. Gail McCarver, Ronald N. Hines	236
15	Critical role of histidine residues in cyclohexanone monooxygenase expression, cofactor binding and catalysis 2003 ·Chemico-Biological Interactions ·Matthew James Cheesman, M. Byron Kneller, Allan E. Rettie	16
16	ESI- and MALDI-MS Analysis of Cyclohexanone Monooxygenase from Acinetobacter NCIB 9871 2001 ·Biochemical and Biophysical Research Communications ·M. Byron Kneller, Matthew James Cheesman, Allan E. Rettie	9
17	Immunoquantitation of FMO1 in Human Liver, Kidney, and Intestine 2000 ·Drug Metabolism and Disposition ·Catherine K. Yeung, Dieter Lang, Kenneth E. Thummel, Allan E. Rettie	106
18	Structural Forms of Phenprocoumon and Warfarin That Are Metabolized at the Active Site of CYP2C9 1999 ·Archives of Biochemistry and Biophysics ·Minxia M. He, Kenneth R. Korzekwa, Jeffrey P. Jones, Allan E. Rettie, William Trager	73
19	Oxidation of Acetaminophen to Its Toxic Quinone Imine and Nontoxic Catechol Metabolites by Baculovirus-Expressed and Purified Human Cytochromes P450 2E1 and 2A6 1998 ·Chemical Research in Toxicology ·Weiqiao Chen, (unknown), (unknown), Raimund M. Peter, Allan E. Rettie, William Trager, Sidney D. Nelson	181
20	P450-Catalyzed In-Chain Desaturation of Valproic Acid: Isoform Selectivity and Mechanism of Formation of Δ3-Valproic Acid Generated by Baculovirus- Expressed CYP3A1 1998 ·Archives of Biochemistry and Biophysics ·Michael B. Fisher, (unknown), Vera Ribeiro, Maria Celeste Lechner, Allan E. Rettie	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact